![James D. Thompson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James D.
Thompson worked as a Director of Biology Research at Sirna Therapeutics, Inc., a Director of Research & Development at Genta, Inc., and a Vice President of Pharmaceutical Development at Quark Pharmaceuticals, Inc. He received an undergraduate degree from Temple University and a doctorate degree from Hahnemann University.
| Companies | Position | End |
|---|---|---|
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Chief Tech/Sci/R&D Officer | - |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Corporate Officer/Principal | - |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
